Bioton (LTS:0DTR) Total Liabilities : zł195.6 Mil (As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Bioton Total Liabilities?

Bioton's Total Liabilities for the quarter that ended in Mar. 2024 was zł195.6 Mil.

Bioton's quarterly Total Liabilities declined from Sep. 2023 (zł220.24 Mil) to Dec. 2023 (zł215.87 Mil) and declined from Dec. 2023 (zł215.87 Mil) to Mar. 2024 (zł195.63 Mil).

Bioton's annual Total Liabilities declined from Dec. 2021 (zł243.61 Mil) to Dec. 2022 (zł204.27 Mil) but then increased from Dec. 2022 (zł204.27 Mil) to Dec. 2023 (zł215.87 Mil).

Bioton Total Liabilities Historical Data

The historical data trend for Bioton's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioton Total Liabilities Chart

Bioton Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

299.76

247.46

243.61

204.27

215.87

Bioton Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															209.97	211.36	220.24	215.87	195.63

Bioton Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Bioton's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	165.59	+	(12.677	+	35.572
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	2.027)
	=	215.9

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	822.224	-	606.358
	=	215.9

Bioton's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	148.634	+	(10.843	+	34.127
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	2.027)
	=	195.6

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	796.994	-	601.363
	=	195.6

Bioton Total Liabilities Related Terms

Thank you for viewing the detailed overview of Bioton's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioton (LTS:0DTR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioton SA (LTS:0DTR) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

BIO:Poland 7U5:Germany

Address

Ul. Staro?ci?ska 5, Warszawa, POL, 02-516

Website

http://www.bioton.pl

Bioton SA is a Poland based company engaged in the principal business activity of manufacturing medicines and pharmaceutical preparations and production of pharmaceutical substances. The products of the company include recombinant human insulin in pharmaceutical substance form and as preparations for injections; glimepiride, an oral hypoglycemic drug; and metformin, an oral hypoglycemic drug. Its products line focuses on diet supplements, products for particular nutritional uses and cosmetics dedicated to patients with certain health problems. The group operates in Poland and internationally, of which majority of the revenue is derived from Poland.

Bioton (LTS:0DTR) Headlines

No Headlines